Inside Druid AI’s ‘Build Your Own Agent’ Model

The Druid AI platform offers a suite of agents to support the building of enterprise agents, including a conversational ...
Healthcare Dive

CMMI to launch model to lower Medicaid drug spending

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries with participating pharmaceutical manufacturers. Under ...
IEEE

MHGCN: A Multi-Channel Hybrid Graph Convolutional Neural Network for Cancer Drug Response Prediction

Abstract: Due to the heterogeneity of cancer cells, personalized treatment plans for cancer patients remain a continuous concern. High-throughput drug screening technology has led to the development ...
Medscape

‘Designer Drug’ Shows Early Neuroprotective Signal in Acute Ischemic Stroke

BARCELONA, Spain — An experimental drug that takes a novel approach to protecting injured brain cells has shown promising results in an early Phase 2 trial of patients with acute ischemic stroke (AIS) ...
IEEE

DHAG-DTA: Dynamic Hierarchical Affinity Graph Model for Drug-Target Binding Affinity Prediction

Abstract: Computational methods for predicting drug-target binding affinity (DTA) are critical for large-scale screening of prospective therapeutic compounds during drug discovery. Deep neural ...
Frontiers

Development of a diagnostic model for MASLD and identification of daidzein as the potential drug using bioinformatics analysis and experiments

1 Department of Infectious Diseases, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China 2 Department of Endocrinology, Shanghai East Hospital, School of Medicine, Tongji ...
洗護用品和肥皂

Worker power as a business model: the case of the No Sweat T-shirt project

No Sweat has long asserted that the garment industry's deeply entrenched labour abuses are symptomatic of unregulated global capitalism. The concept of ‘ethical production’, promoted by corporate ...
C&EN

MFGNN-DSA: A Model for Predicting Drug–Side Effect Associations via Multifeature Fusion and Graph Neural Networks

Institute of Computational Medicine, School of Artificial Intelligence, Hebei University of Technology, Tianjin 300401, China ...
FiercePharma

Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing deals featuring Chinese biotechs. Fierce's deep dive into the dispute between Novo Nordisk and KBP Biosciences ...
The Economist

Brute force is no match for today’s high-tech drug-runners

HeLLFIRE MISSILES used to strike terrorist hideouts in the mountains of Afghanistan. Now they rain down on the sparkling waters of the Caribbean. Small boats and their crews, alleged drug-traffickers, ...
C&EN

Cocrystal Network-Based Recommendation: A Multi-Objective Random Walk-Based Network Model for Virtual Screening of Drug–Drug Cocrystals

Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, ...
FierceBiotech

Takeda turns to AI drug designer for $1B biobucks deal after whittling down R&D focus

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.